country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

J Med Chem. 1996 Feb 2;39(3):665-8. doi: 10.1021/jm950395a.

T M Willson ¹ , J E Cobb , D J Cowan , R W Wiethe , I D Correa , S R Prakash , K D Beck , L B Moore , S A Kliewer , J M Lehmann

Affiliations

PMID: 8576907 DOI: 10.1021/jm950395a

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-17386

Rosiglitazone

99.94%, PPARγ Agonist

target: PPAR; TRP Channel; Autophagy; Ferroptosis; Apoptosis

Research Areas: Neurological Disease; Metabolic Disease; Inflammation/Immunology; Cancer
HY-14600

Rosiglitazone maleate

99.73%, PPARγ Activator

target: PPAR; TRP Channel; Autophagy; Ferroptosis

Research Areas: Metabolic Disease; Inflammation/Immunology; Cancer
HY-17386A

Rosiglitazone hydrochloride

99.81%, PPARγ Agonist

target: PPAR; TRP Channel; Autophagy; Ferroptosis; Apoptosis

Research Areas: Neurological Disease; Metabolic Disease; Inflammation/Immunology; Cancer
HY-W011220

Ciglitazone

99.74%, PPARγ Agonist

target: PPAR

Research Areas: Cardiovascular Disease; Cancer
HY-17386R

Rosiglitazone (Standard)

99.59%, PPARγ Agonist

target: Reference Standards; PPAR; TRP Channel; Autophagy; Ferroptosis; Apoptosis

Research Areas: Neurological Disease; Metabolic Disease; Inflammation/Immunology; Cancer
HY-17386S1

Rosiglitazone-d₄

99.72%, Stable Isotope

target: Ferroptosis; Autophagy; TRP Channel; PPAR; Apoptosis; Isotope-Labeled Compounds

Research Areas: Neurological Disease; Metabolic Disease; Inflammation/Immunology; Cancer
HY-17386S

Rosiglitazone-d₃

Stable Isotope

target: Isotope-Labeled Compounds; PPAR; TRP Channel; Autophagy; Ferroptosis

Research Areas: Neurological Disease; Metabolic Disease; Inflammation/Immunology; Cancer
HY-17386B

Rosiglitazone potassium

99.13%, PPARγ Agonist

target: PPAR; TRP Channel; Autophagy; Apoptosis; Ferroptosis

Research Areas: Neurological Disease; Metabolic Disease; Inflammation/Immunology; Cancer
HY-14600R

Rosiglitazone maleate (Standard)

PPARγ Activator

target: Reference Standards; PPAR; TRP Channel; Autophagy; Ferroptosis

Research Areas: Metabolic Disease; Inflammation/Immunology; Cancer
HY-B0700

Rosiglitazone sodium

PPAR Activator

target: PPAR; TRP Channel; Autophagy

Research Areas: Metabolic Disease; Inflammation/Immunology
HY-17386AR

Rosiglitazone hydrochloride (Standard)

PPARγ Agonist

target: PPAR; TRP Channel; Autophagy; Ferroptosis; Apoptosis; Reference Standards

Research Areas: Neurological Disease; Metabolic Disease; Inflammation/Immunology; Cancer